Failure of treatment and adverse effects: long‐term Participants with surgery and symptom recurrence · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes failure of treatment and adverse effects: long‐term Participants… compared with microfracture (very low certainty).
1 finding from 1 review
Pain North Americal Spine Society pain scores. Scale from: 0 to 100 (higher scores indicate less pain). · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes pain: long‐term KOOS Pain score. Scale 0 to 100; higher scores =… compared with microfracture (very low certainty).
1 finding from 1 review
Activity: long term (5 or more years · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes activity: long term (5 or more years compared with microfracture (very low certainty).
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
Behavioural treatment probably leads to higher prolonged abstinence at longest compared with no treatment or usual care (moderate certainty).
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
Pharmacological treatment probably leads to higher point prevalence abstinence at longest compared with a different pharmacological treatment (moderate certainty).
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
Pharmacological treatment leads to higher prolonged abstinence at longest compared with placebo (high certainty).
5 findings from 1 review
RR 2.53 [1.83, 3.5]
4 studies · 1429 participants
High
RR 2.6 [1.29, 5.24]
1 study · 370 participants
High
RR 2.03 [1.26, 3.28]
2 studies · 503 participants
Moderate
Show 2 more findings
Clinically important change in life skills (long term) ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life (long term) ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost‐effectiveness (long term) ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinically important change in life skills (long term) · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life (long term) · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost‐effectiveness · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found